Posted on April 22nd, 2013 by Logan Lafferty
New guidelines have been developed to treat recently diagnosed multiple myeloma in patients who are not participating in clinical trials. The guidelines give physicians practical, easy to follow recommendations for providing initial therapy, stem cell transplant, and maintenance therapy. "Multiple myeloma is an incurable blood cancer that affects more than 20,000 people in the US each year," said lead author Joseph Mikhael, MD, a hematologist at the Mayo Clinic in Arizona.
Oncology Nurse Advisor by Kathy Boltz, PhD.
You must be logged-in to the site to post a comment.